The Alliance for Pulmonary Hypertension (AfPH) is back with the third instalment of their 2026 webinar series exploring how new science and AI are transforming pulmonary arterial hypertension care.
This session taking place on September 28 at 6 pm CEST brings together leading experts from the US, UK, and Netherlands to explore where the field is heading.
All four talks point toward the same underlying shift in pulmonary arterial hypertension care — from reactive, late-stage diagnosis and generalized treatment toward earlier detection, continuous monitoring, and individualized therapy, powered by AI and better data. For patients, that translates into the possibility of catching the disease sooner and getting treatment tailored to them specifically, rather than a standard protocol.
The session opens with a welcome from Nils Fischer (USA), and closes with a live Q&A where you can put your questions directly to our speakers.
Whether you’re a clinician, researcher, or patient advocate, this is a chance to hear directly from the people shaping the future of pulmonary arterial hypertension diagnosis and care.
IMPORTANT: The slides, video recording and full transcript will be uploaded to the Knowledge Sharing Platform shorty after the webinar. The transcript can be translated into 40 languages directly online.
Link to join on the day: https://us06web.zoom.us/j/82348925091?pwd=J03jIBND1sN2xX6SjgyzZZ1XyLPdgO.1#success
